Contact
Please use this form to send email to PR contact of this press release:
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
TO:
Please use this form to send email to PR contact of this press release:
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
TO: